Feedback / Questions
lanifibranor (IVA337) - Inventiva, Hepalys Pharma
https://www.biospace.com/article/releases/inventiva-announces-the-publication-in-nature-communications-of-additional-results-from-native-phase-iib-clinical-trial-demonstrating-improvement-of-markers-of-cardiometabolic-health-in-patients-with-mash-nash-treated-with-lanifibranor/
May 13, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next